FAQs about the COVID-19 Vaccine

Your level of immunity from the virus can vary, depending on severity of your illness. The vaccine provides a consistent level of immunity across the board, which ensures that you are as protected as possible. If you have tested positive, you are encouraged to be vaccinated, but may be lower on the priority list.

Learn more from the Mile Bluff team.

We don’t know the answer to this for the vaccine or the virus.

Learn more from the Mile Bluff team.

A small number of people may develop symptoms that mimic the virus. This is more likely with the second dose of the vaccine. This is not because an individual is getting sick with the virus; it is they body’s reaction as it develops the proper immune response to COVID-19. Patients who have previously tested positive for COVID, have experienced a higher incidence of side effects.

The most common immune responses are fatigue (4.2% of recipients), headache (2.4%), muscle pain (1.8%), chills (1.7%), and pain and redness at the injection site (1.4%). Severe reactions occurred in only 0.6% of individuals.

These are all very similar to the occurrence of reactions to the influenza vaccine.

Learn more from the Mile Bluff team.

Symptoms have most commonly lasted just 24 hours, but can stick around for up to 3 days. Those who develop symptoms from the vaccine should contact their healthcare provider and employer, if applicable.

Unless directed by your primary care provider, you should get both doses of the vaccine. With one injection, your immunity will not be boosted to the highest level it could reach. If you do experience a severe reaction, contact your provider immediately.

No. There is no trace of the virus in the COVID vaccine. Any symptoms a person experiences after injection are the body’s reaction as it builds an immune response.

Learn more from the Mile Bluff team.

To be approved, a vaccine must pass rigorous safety and efficacy testing. The FDA will not approve a vaccine unless it prevents disease or decreases severity in at least 50% of those who receive it. Current data on the COVID-19 vaccine show 90+% efficacy.

Plus, the COVID-19 vaccine was tested on a larger scale than many of today’s trusted vaccines. In addition, while the vaccine is a new way to fight against COVID-19, the technology used to develop this type of vaccine has been in development for well over a decade. It was originally introduced with the intention of fighting cancer, but attention was switched to COVID when the virus began to spread rapidly across the world.

It’s true that this vaccine was ready for distribution faster than any other vaccine in history. However, Operation Warp Speed was not completed by cutting any corners.

Generally, when vaccines are developed, the manufacturers wait for approval before producing any of the vaccine that is being tested. This protects the companies from losing out on their work and money if a vaccine doesn’t work. With the COVID-19 vaccines, the manufacturers ran the risk of going to production during testing, in anticipation that the vaccines would work. This would allow them to begin distribution as soon as there was approval. That risk is paying off, and is the reason we have the vaccine in-hand that much sooner.

Learn more about the vaccine "myths" from the Mile Bluff team.

According to the CDC website: “Vaccine doses purchased with U.S. taxpayer dollars will be given to the American people at no cost.” There is, however, likely to be an administration fee for those who are vaccinated. At this time, we do not know if or how those fees may be covered by insurance.

This is not suggested. The recommendation is to have everyone vaccinated, even individuals with antibodies.

At this point, the focus is on getting the COVID vaccine to as many people as possible, so that it can be effective on a global scale. There are currently no plans to add the COVID vaccine to another.

There is no conclusive evidence on this, so it’s always best to continue to practice all safety recommendations and precautions.

It is expected that some people who receive the vaccines may be protected against severe infection, but not necessarily be prevented from having a mild or asymptomatic infection if later exposed to the virus. These individuals would have the potential to pass the virus on to others.

In addition, while we’ve seen the vaccine to be effective in trials, there is still a small percentage of people who will not develop immunity from it. These individuals may become ill if exposed to the virus sometime after vaccination, and may also then pass the virus on to others.

Yes. Masking recommendations will not change. Wearing a mask is the right thing to do. It helps those around you feel safer in your presence; and helps prevent any possible spread of the virus, even after being vaccinated.

Learn more from the Mile Bluff team.

If you have been diagnosed with COVID-19 and are in the severe phase of your illness, you should postpone being vaccinated until your fever subsides and/or your other symptoms resolve.

If you’ve experienced an anaphylactic reaction to any ingredient in the vaccine (like polyethylene glycol), this vaccine is not recommended for you.

If you have received Bamlanivimab or Regeneron to treat COVID, you should postpone being vaccinated until at least 90 days after your last treatment.

At this time, COVID-19 vaccines are not recommended for anyone under the age of 16.

See additional information on this page for recommendations for other specific groups.

Learn more from the Mile Bluff team.

If you have a history of vaccine reaction, and/or you commonly react to medications, and/or you've experienced an anaphylactic reaction to any medication (especially a vaccine), the CDC recommends that you consult your primary care provider before being vaccinated for COVID-19.

While the COVID-19 vaccines are distinctly different from any other vaccine, the CDC defers to your primary care provider to help you make the decision that is best for you.

The CDC recommends that pregnant and nursing patients be vaccinated. Although there were not separate studies for these individuals, there were enough participants in the studies who were pregnant and nursing to project success with the vaccine.

There is no evidence to suggest that the vaccines have a negative impact on fertility. In fact, the CDC notes that there were dozens of participants in the clinical trials who became pregnant during the trials, without complications.

If you have an autoimmune disorder, the Lupus Foundation and CDC recommend vaccination. However, if you are on immuno-suppressive medications, you should consult with your prescribing provider before being vaccinated. Timing out the vaccine with your medication may be recommended to optimize your immune response.

If you are vaccinated for COVID-19, it is recommended that you do not receive any other vaccines within two weeks of your COVID-19 vaccination.

If you are interested in reading more about vaccines, two great sources are the CDC and the Wisconsin Department of Health Services. For up-to-date information about the vaccine available at Mile Bluff, visit the Moderna website. For information about the vaccine being distributed by the Juneau County Health Department, visit the FDA website and click on the link to the Fact Sheet for Recipients and Caregivers.